Bloomberg says that drug sales are forecast to grow at their slowest ever rate in 44 years.
The WSJ (sub required??) reminds us that FDA approvals for NMEs are slow, and on a downward curve.
Perhaps it’s time for the pharma industry to really think about Pharma Futorology
Please read the standard disclaimer
Technorati Tags: Phama
Your email is never published nor shared. Required fields are marked *
You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>
Grim days for pharma
Bloomberg says that drug sales are forecast to grow at their slowest ever rate in 44 years.
The WSJ (sub required??) reminds us that FDA approvals for NMEs are slow, and on a downward curve.
Perhaps it’s time for the pharma industry to really think about Pharma Futorology
Please read the standard disclaimer
Technorati Tags: Phama